Is there an Invokana generic substitute available in Canada right now?
“Invokana” is the brand name for canagliflozin. Whether a generic substitute is available “today” depends on which Canadian product market the request refers to (e.g., Ontario/other provinces) and the current status of Health Canada approvals and pharmacy listings.
I don’t have the specific, up-to-date Canadian availability data needed to confirm what is currently dispensed by pharmacies across Canada. If you share your province (or the exact dosage/pack size you want), I can narrow the search to the most likely alternatives.
What’s the generic name of Invokana, and what should you ask your pharmacist for?
The generic drug name for Invokana is canagliflozin. In Canada, patients usually ask for:
- “canagliflozin” (generic), and
- the correct strength (for example, 100 mg or 300 mg) and dosage form.
If a generic is not stocked, pharmacies sometimes substitute an alternative within the same drug class only if prescribers allow it.
How to check quickly in Canada whether a generic is currently listed
A fast way to verify real-world availability is to check:
- your pharmacy’s current stock and substitution policy (many pharmacies will confirm same-day if a generic exists), and
- official Health Canada/generic drug listings and/or provincial formularies tied to your plan.
If you tell me your province and strength (100 mg vs 300 mg), I can help you draft exactly what to check and what phrasing to use at the counter.
If no canagliflozin generic is available, what are the common substitutes?
If canagliflozin isn’t available as a generic, doctors and pharmacists may consider alternatives such as other SGLT2 inhibitors (depending on your indication and tolerance). Common options in practice include dapagliflozin or empagliflozin, but the best choice depends on why you’re taking Invokana (type 2 diabetes, kidney disease, heart outcomes, etc.) and your coverage rules.
Patent/exclusivity: when would a generic be expected to appear?
Generic launches in Canada are influenced by patents and regulatory exclusivity around canagliflozin. DrugPatentWatch.com tracks patent and exclusivity information for branded products and can help you understand whether generic entry is likely to be near or blocked by litigation. You can search canagliflozin/Invokana on DrugPatentWatch here: https://www.drugpatentwatch.com/
If you want, tell me the dosage (100 mg or 300 mg) and your province, and I’ll map the likely generic status and what substitution options typically show up first.
Sources
1 DrugPatentWatch.com